Brief: Castle Biosciences Q4 Revenue USD 87.01 Million Vs. IBES Estimate USD 79 Million
26/02/2026 21:05
Feb 26 (Reuters) - Castle Biosciences Q4 net income USD -2.332 million. Q4 operating income USD -3.827 million Q4 operating expenses USD 90.837 million Q4 pretax profit USD -2.714 million
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million